RCKTW Rocket Pharmaceuticals, Inc. - Warrant
$0,00
Fiyat · Ağu 19, 2026
Temel veriler itibarıyla Ağu 10, 2026
52 Haftlık Aralık
$0–$0
2% of range
Analist Derecelendirmesi
—
Fiyat Hedefi
—
P/E (TTM)
-0.0
ROE
-70.7%
Net Kâr Marjı
—
RCKTW Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
Fiyat
$0.00
Piyasa Değeri
$108.3K
P/E (TTM)
-0.0
EPS (TTM)
$-2.01
Gelir (TTM)
$0
Temettü Verimi
—
ROE
-70.7%
D/E Borç/Özsermaye
—
52 Haftlık Aralık
$0 – $0
RCKTW Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
Configure
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Gelir ve Net Gelir
$0
2016-12-31
→
2025-12-31
Hisse Başına Kâr
$-2.01
2019-12-31
→
2025-12-31
Serbest Nakit Akışı
$-190M
2016-12-31
→
2025-12-31
Marjlar
—
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Metrik
5 Yıllık trend
RCKTW
Akran Ortalaması
P/E (TTM)
-0.0
—
P/B (F/D)
0.0
—
Price / FCF (Fiyat / Serbest Nakit Akışı)
-0.0
—
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Metrik
5 Yıllık trend
RCKTW
Akran Ortalaması
ROA
-52.0%
—
ROE
-70.7%
—
ROIC
-83.6%
—
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Metrik
5 Yıllık trend
RCKTW
Akran Ortalaması
Current Ratio (Cari Oran)
6.4
—
Quick Ratio (Cari Oran)
6.3
—
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Metrik
5 Yıllık trend
RCKTW
Akran Ortalaması
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
Metrik
5 Yıllık trend
RCKTW
Akran Ortalaması
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 16
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $142M | $171M | $186M | $166M | $125M | $105M | $58M | $53M | $15M | $6M | |
| SG&A Expense | $87M | $102M | $73M | $59M | $42M | $29M | $18M | $18M | $5M | $2M | |
| Operating Expenses | $232M | $273M | $260M | $224M | $167M | $134M | $76M | $71M | $20M | $8M | |
| Operating Income | $-232M | $-273M | $-260M | $-224M | $-167M | $-134M | $-76M | $-71M | $-20M | $-8M | |
| Interest Expense | $2M | $2M | $2M | $2M | $3M | $7M | $6M | $6M | $0 | $0 | |
| Interest Income | · | · | · | · | · | · | · | · | $819.0K | $443.0K | |
| Other Non-op | · | · | · | $2M | $-2M | $-5M | · | · | · | · | |
| Pretax Income | $-223M | $-259M | · | · | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | · | · | · | · | · | · | · | |
| Net Income | $-223M | $-259M | $-246M | $-222M | $-169M | $-140M | $-77M | $-75M | $-20M | $-8M | |
| EPS (Basic) | $-2.01 | $-2.73 | $-2.92 | $-3.26 | $-2.67 | $-2.52 | $-1.58 | · | · | · | |
| EPS (Diluted) | $-2.01 | $-2.73 | $-2.92 | $-3.26 | $-2.67 | $-2.52 | $-1.58 | · | · | · | |
| Shares (Basic) | 111,123,770 | 94,807,773 | 84,009,004 | 68,148,925 | 63,235,417 | 55,380,740 | 49,010,358 | · | · | · | |
| Shares (Diluted) | 111,123,770 | 94,807,773 | 84,009,004 | 68,148,925 | 63,235,417 | 55,380,740 | 49,010,358 | · | · | · | |
| EBITDA | $-223M | $-266M | $-255M | $-224M | $-167M | $-133M | $-76M | $-71M | $-27M | $-42M |
Bilanço 25
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $78M | $164M | $56M | $141M | $233M | $297M | $185M | $111M | $18M | $30M | |
| Short-term Investments | $111M | $209M | $317M | $216M | $156M | $186M | $119M | $94M | $0 | $97M | |
| Prepaid Expense | $4M | $6M | $5M | $8M | $3M | $5M | $4M | $3M | $813.0K | $2M | |
| Current Assets | $193M | $378M | $378M | $364M | $392M | $487M | $308M | $209M | $19M | $128M | |
| PP&E (Net) | $28M | $37M | $39M | $29M | $22M | $19M | $30M | $2M | $985.0K | $1M | |
| PP&E (Gross) | $57M | $58M | $53M | $38M | $28M | $21M | $30M | $3M | $1M | $2M | |
| Accum. Depreciation | $29M | $21M | $14M | $9M | $5M | $2M | $905.0K | $479.0K | $270.0K | $431.0K | |
| Goodwill | $39M | $39M | $39M | $39M | $31M | $31M | $31M | $31M | $0 | · | |
| Intangibles | $25M | $25M | $25M | $26M | $0 | · | · | · | · | · | |
| Other Non-current Assets | · | · | · | · | · | · | · | · | $168.0K | $168.0K | |
| Total Assets | $330M | $528M | $566M | $552M | $497M | $591M | $372M | $251M | $20M | $130M | |
| Accounts Payable | $27M | $38M | $46M | $37M | $20M | $25M | $17M | $15M | $5M | $2M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | $2M | $4M | |
| Current Liabilities | $30M | $41M | $49M | $39M | $22M | $33M | $18M | $15M | $5M | $7M | |
| Capital Leases | $3M | $3M | $3M | $1M | $905.0K | $498.0K | $1M | $0 | · | · | |
| Other Non-current Liabilities | $1M | $1M | $3M | $3M | $80.0K | $136.0K | $23.0K | $457.0K | $403.0K | $477.0K | |
| Total Liabilities | $53M | $64M | $74M | $62M | $42M | $87M | $65M | $57M | $5M | $56M | |
| Common Stock | $1M | $1M | $903.0K | $791.0K | $645.0K | $610.0K | $548.0K | $452.0K | $68.0K | $67.0K | |
| Paid-in Capital | $1.72B | $1.68B | $1.45B | $1.20B | $946M | $826M | $490M | $300M | $5M | · | |
| Retained Earnings | $-1.44B | $-1.22B | $-959M | $-714M | $-492M | $-323M | $-183M | $-106M | $-31M | $-239M | |
| Treasury Stock | · | · | $0 | $47.0K | $0 | $0 | $53.0K | $668.0K | $0 | · | |
| AOCI | $-31.0K | $66.0K | $319.0K | $-357.0K | $-161.0K | $-42.0K | $20.0K | $-127.0K | $0 | $-54.0K | |
| Stockholders' Equity | $277M | $463M | $493M | $490M | $455M | $504M | $307M | $194M | $16M | $8M | |
| Liabilities + Equity | $330M | $528M | $566M | $552M | $497M | $591M | $372M | $251M | $20M | $130M | |
| Shares Outstanding | 108,319,783 | 106,453,818 | 90,282,267 | 79,120,741 | 64,505,889 | 60,996,367 | 54,769,030 | 45,144,736 | 6,795,627 | 6,746,579 |
Nakit Akışı 15
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $9M | $7M | $5M | $4M | $3M | $1M | $426.0K | $330.0K | · | · | |
| Stock-based Comp | $37M | $44M | $39M | $31M | $29M | $19M | $13M | $14M | $1M | $274.0K | |
| Restructuring | $3M | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | $-13M | $-2M | $6M | · | · | $45M | · | · | · | · | |
| Operating Cash Flow | $-190M | $-210M | $-195M | $-178M | $-121M | $-75M | $-65M | $-54M | $-16M | $-6M | |
| CapEx | $440.0K | $6M | $16M | $8M | $8M | $21M | $23M | $1M | $760.0K | $335.0K | |
| Investing Cash Flow | $104M | $132M | $-98M | $-69M | $19M | $-97M | $-39M | $-5M | $-760.0K | $-335.0K | |
| Stock Issued | · | · | · | $47M | $0 | $0 | $31.0K | $154M | $0 | $0 | |
| Stock Repurchased | · | · | · | · | $0 | $72.0K | $0 | $0 | $0 | $0 | |
| Net Stock Activity | · | · | · | $47M | $11M | $281M | $178M | $153M | · | · | |
| Financing Cash Flow | $148.0K | $186M | $208M | $155M | $38M | $283M | $178M | $154M | $25M | $16.0K | |
| Net Change in Cash | · | · | · | · | · | · | · | · | $49M | $-50M | |
| Taxes Paid | $0 | · | · | · | $0 | $0 | $26.0K | $2.0K | $0 | $0 | |
| Free Cash Flow | $-190M | $-216M | $-211M | $-186M | $-129M | $-95M | $-88M | $-55M | $-26M | $-38M | |
| Levered FCF | $-192M | · | · | · | · | · | · | · | · | · |
Kârlılık 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -52.0% | -47.3% | -43.9% | -42.3% | -31.1% | -29.0% | -24.8% | -54.9% | -25.5% | -35.3% | |
| ROE | -70.7% | -65.3% | -47.5% | -51.8% | -36.0% | -37.5% | -28.7% | -44.1% | -105.1% | -96.6% | |
| ROIC | -83.6% | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.4 | 9.3 | 7.8 | 9.3 | 17.7 | 14.9 | 16.8 | 13.6 | 24.8 | 17.8 | |
| Quick Ratio | 6.3 | 9.2 | 7.7 | 9.1 | 17.5 | 14.8 | 16.6 | 13.4 | 24.6 | 17.5 | |
| Interest Coverage | -122.6 | -144.9 | -138.5 | -120.5 | -56.2 | -19.3 | -12.8 | -11.8 | -7.5 | -29.5 |
Verimlilik 1
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | · |
Değerleme (TTM) 9
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-223M | $-259M | $-246M | $-222M | $-169M | $-140M | $-77M | $-75M | $-20M | $-8M | |
| Market Cap | $3M | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | · | · | · | · | · | · | · | · | · | |
| P / Cash Flow | -0.0 | · | · | · | · | · | · | · | · | · | |
| P / FCF | -0.0 | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -6590.2% | · | · | · | · | · | · | · | · | · |
Gelir Tablosu 14
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| R&D Expense | $29M | $29M | $34M | $43M | $36M | $37M | $42M | $46M | $45M | $42M | $47M | $51M | $46M | $43M | $41M | $31M | |
| SG&A Expense | $17M | $15M | $18M | $25M | $28M | $25M | $27M | $27M | $22M | $22M | $19M | $17M | $16M | $15M | $13M | $12M | |
| Operating Expenses | $47M | $44M | $52M | $71M | $64M | $63M | $69M | $74M | $67M | $63M | $65M | $69M | $62M | $58M | $54M | $43M | |
| Operating Income | $-47M | $-44M | $-52M | $-71M | $-64M | $-63M | $-69M | $-74M | $-67M | $-63M | $-65M | $-69M | $-62M | $-58M | $-54M | $-43M | |
| Interest Expense | $473.0K | $473.0K | $473.0K | $473.0K | $472.0K | $473.0K | $471.0K | $471.0K | $471.0K | $470.0K | $469.0K | $468.0K | $468.0K | $465.0K | $465.0K | $464.0K | |
| Pretax Income | $132M | · | · | $-69M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $9M | · | · | $0 | · | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income | $123M | $-43M | $-50M | $-69M | $-61M | $-60M | $-67M | $-70M | $-62M | $-60M | $-62M | $-66M | $-58M | $-58M | $-54M | $-43M | |
| EPS (Basic) | $1.09 | $-0.38 | $-0.45 | $-0.62 | $-0.56 | $-0.62 | $-0.71 | $-0.74 | $-0.66 | $-0.62 | $-0.75 | $-0.82 | $-0.73 | $-0.87 | $-0.83 | $-0.67 | |
| EPS (Diluted) | $1.08 | $-0.38 | $-0.45 | $-0.62 | $-0.56 | $-0.62 | $-0.71 | $-0.74 | $-0.66 | $-0.62 | $-0.75 | $-0.82 | $-0.73 | $-0.87 | $-0.83 | $-0.67 | |
| Shares (Basic) | 112,844,880 | -221,560,474 | 111,571,136 | 111,019,647 | 110,093,461 | -186,646,845 | 94,158,491 | 93,746,243 | 93,549,884 | -158,552,997 | 82,636,120 | 80,472,362 | 79,453,519 | 66,215,535 | 65,476,531 | 64,509,721 | |
| Shares (Diluted) | 114,513,964 | -221,560,474 | 111,571,136 | 111,019,647 | 110,093,461 | -186,646,845 | 94,158,491 | 93,746,243 | 93,549,884 | -158,552,997 | 82,636,120 | 80,472,362 | 79,453,519 | 66,215,535 | 65,476,531 | 64,509,721 | |
| EBITDA | $-45M | · | $-50M | $-71M | $-62M | · | $-68M | $-72M | $-66M | · | $-65M | $-69M | $-62M | $-58M | $-54M | $-43M |
Bilanço 23
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $225M | $78M | $76M | $33M | $50M | $164M | $66M | $39M | $35M | $56M | $226M | $45M | $65M | $197M | $188M | $131M | |
| Short-term Investments | $59M | $111M | $147M | $239M | $268M | $209M | $170M | $240M | $295M | $317M | $212M | $262M | $267M | $110M | $134M | $216M | |
| Prepaid Expense | $6M | $4M | $5M | $6M | $6M | $6M | $6M | $14M | $15M | $5M | $10M | $5M | $7M | $5M | $4M | $7M | |
| Current Assets | $290M | $193M | $228M | $277M | $324M | $378M | $242M | $293M | $345M | $378M | $447M | $312M | $338M | $311M | $326M | $354M | |
| PP&E (Net) | $25M | $28M | $30M | $33M | $35M | $37M | $39M | $40M | $39M | $39M | $37M | $33M | $31M | $26M | $25M | $24M | |
| PP&E (Gross) | $57M | $57M | $57M | $58M | $58M | $58M | $58M | $57M | $55M | $53M | $49M | $44M | $41M | $34M | $32M | $30M | |
| Accum. Depreciation | $32M | $29M | $27M | $26M | $24M | $21M | $19M | $18M | $16M | $14M | $13M | $11M | $10M | $8M | $7M | $6M | |
| Goodwill | $39M | $39M | $39M | $39M | $39M | $39M | $39M | $39M | $39M | $39M | $39M | $39M | $39M | $31M | $31M | $31M | |
| Intangibles | $25M | $25M | $25M | $25M | $25M | $25M | $25M | $25M | $25M | $25M | $25M | $26M | $26M | · | · | · | |
| Total Assets | $423M | $330M | $368M | $421M | $471M | $528M | $394M | $446M | $499M | $566M | $599M | $462M | $515M | $417M | $432M | $460M | |
| Accounts Payable | $28M | $27M | $28M | $41M | $32M | $38M | $37M | $35M | $30M | $46M | $31M | $31M | $29M | $28M | $22M | $20M | |
| Current Liabilities | $31M | $30M | $31M | $43M | $35M | $41M | $40M | $38M | $33M | $49M | $33M | $34M | $31M | $30M | $24M | $23M | |
| Capital Leases | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $3M | $3M | $3M | $4M | $492.0K | $606.0K | $719.0K | |
| Other Non-current Liabilities | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $3M | $2M | $2M | $2M | $37.0K | $51.0K | $65.0K | |
| Total Liabilities | $54M | $53M | $54M | $67M | $59M | $64M | $64M | $62M | $58M | $74M | $58M | $59M | $56M | $50M | $44M | $43M | |
| Common Stock | $1M | $1M | $1M | $1M | $1M | $1M | $911.0K | $910.0K | $906.0K | $903.0K | $901.0K | $805.0K | $804.0K | $678.0K | $658.0K | $645.0K | |
| Paid-in Capital | $1.73B | $1.72B | $1.71B | $1.70B | $1.69B | $1.68B | $1.49B | $1.48B | $1.46B | $1.45B | $1.44B | $1.24B | $1.23B | $1.01B | $977M | $952M | |
| Retained Earnings | $-1.37B | $-1.44B | $-1.40B | $-1.35B | $-1.28B | $-1.22B | $-1.16B | $-1.09B | $-1.02B | $-959M | $-900M | $-838M | $-772M | $-647M | $-589M | $-535M | |
| Treasury Stock | · | · | · | · | · | · | · | · | · | · | $0 | $47.0K | $47.0K | · | · | · | |
| AOCI | $-106.0K | $-31.0K | $-9.0K | $-107.0K | $-27.0K | $66.0K | $213.0K | $-218.0K | $-135.0K | $319.0K | $-508.0K | $-722.0K | $-90.0K | $-596.0K | $-765.0K | $-629.0K | |
| Stockholders' Equity | $369M | $277M | $314M | $354M | $412M | $463M | $330M | $385M | $442M | $493M | $541M | $403M | $459M | $367M | $388M | $418M | |
| Liabilities + Equity | $423M | $330M | $368M | $421M | $471M | $528M | $394M | $446M | $499M | $566M | $599M | $462M | $515M | $417M | $432M | $460M | |
| Shares Outstanding | 109,539,424 | 108,319,783 | 108,208,643 | 107,884,420 | 106,753,886 | 106,453,818 | 91,116,692 | 90,956,613 | 90,646,590 | 90,282,267 | 90,146,602 | 80,518,844 | 80,409,623 | 67,838,803 | 65,837,894 | 64,522,057 |
Nakit Akışı 11
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | · | · | · | |
| Stock-based Comp | $7M | $6M | $10M | $11M | $10M | $11M | $11M | $11M | $10M | $10M | $10M | $10M | $9M | $8M | $7M | $6M | |
| Restructuring | $0 | $-68.0K | $-172.0K | $3M | · | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Other Non-cash | · | · | · | · | $-7M | · | · | · | $-7M | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-40M | $-35M | $-50M | $-49M | $-56M | $-47M | $-52M | $-54M | $-57M | $-29M | $-57M | $-51M | $-58M | $-44M | $-39M | $-39M | |
| CapEx | $8.0K | $80.0K | $-54.0K | $50.0K | $364.0K | $309.0K | $2M | $2M | $2M | $5M | $5M | $4M | $3M | $503.0K | $3M | $2M | |
| Investing Cash Flow | $214M | $36M | $94M | $32M | $-58M | $-38M | $79M | $56M | $35M | $-141M | $48M | $31M | $-37M | $23M | $79M | $-63M | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $0 | · | $0 | $0 | $17M | $29M | $17M | $0 | |
| Net Stock Activity | · | · | · | · | · | · | · | · | $0 | · | · | · | $17M | · | · | $76.0K | |
| Financing Cash Flow | $150.0K | $0 | $-67.0K | $215.0K | $0 | $183M | $176.0K | $2M | $1M | $391.0K | $189M | $182.0K | $18M | $30M | $17M | $76.0K | |
| Free Cash Flow | · | · | · | · | $-56M | · | · | · | $-59M | · | · | · | $-61M | · | · | $-41M |
Kârlılık 3
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | 29.2% | · | -13.2% | -15.9% | -12.6% | · | -13.5% | -15.3% | -12.2% | · | -12.2% | -14.7% | -12.0% | -12.2% | -11.2% | -8.3% | |
| ROE | 34.1% | · | -15.6% | -18.7% | -14.4% | · | -15.3% | -17.7% | -13.8% | · | -13.6% | -16.6% | -13.3% | -13.5% | -12.4% | -9.6% | |
| ROIC | -11.9% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Likidite ve Solventlik 3
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.2 | · | 7.3 | 6.4 | 9.2 | · | 6.0 | 7.8 | 10.5 | · | 13.3 | 9.1 | 10.8 | 10.3 | 13.4 | 15.7 | |
| Quick Ratio | 9.1 | · | 7.1 | 6.3 | 9.0 | · | 5.9 | 7.4 | 10.0 | · | 13.1 | 8.9 | 10.6 | 10.2 | 13.2 | 15.4 | |
| Interest Coverage | -99.2 | · | -110.5 | -150.4 | -136.4 | · | -147.4 | -156.5 | -143.0 | · | -139.5 | -146.9 | -132.9 | -125.8 | -116.6 | -91.7 |
Verimlilik 1
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Değerleme (TTM) 7
| Metrik | Eğilim | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income TTM | $-44M | · | $-247M | $-267M | $-260M | · | $-260M | $-259M | $-248M | · | $-244M | $-236M | $-213M | $-205M | $-182M | $-168M | |
| Market Cap | $2M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -2124.3% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $0 | $0 | $0 | $0 | $0 |
| Net Gelir | $-223M | $-259M | $-246M | $-222M | $-169M |
| Seyreltilmiş Hisse Başı Kâr | $-2.01 | $-2.73 | $-2.92 | $-3.26 | $-2.67 |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Cari Oran | 6.4 | 9.3 | 7.8 | 9.3 | 17.7 |
| Cari Oran | 6.3 | 9.2 | 7.7 | 9.1 | 17.5 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-190M | $-216M | $-211M | $-186M | $-129M |
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
📊
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 10 dosya · $133K toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
Kurumsal faaliyet — Q2 2026 ve önceki çeyrek
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 2 (+1 önceki Ç'ye göre) | 1 (-2 önceki Ç'ye göre) | 0 (0 önceki Ç'ye göre) | 0 (0 önceki Ç'ye göre) | -4K |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | $126.239 | 36.912 | 94,79% | Hisse senetleri |
| CITADEL ADVISORS LLC | $1.860 | 300.000 | 1,40% | Hisse senetleri |
| Sio Capital Management, LLC | $1.480 | 400.000 | 1,11% | Hisse senetleri |
| Walleye Capital LLC | $1.365 | 284.345 | 1,02% | Hisse senetleri |
| RTW INVESTMENTS, LP | $1.190 | 350.000 | 0,89% | Hisse senetleri |
| LMR Partners LLP | $364 | 75.731 | 0,27% | Hisse senetleri |
| SILVERARC CAPITAL MANAGEMENT, LLC | $356 | 104.828 | 0,27% | Hisse senetleri |
| Affinity Asset Advisors, LLC | $278 | 75.000 | 0,21% | Hisse senetleri |
| TORONTO DOMINION BANK | $49 | 99 | 0,04% | Hisse senetleri |
| Clear Street Group Inc. | $0 | 99 | 0,00% | Hisse senetleri |
Şirket yöneticileri 5 içeriden öğrenenler · 0 yöneticiler · 0 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Gaurav Shah | — | 13 Ağustos 2026 S | 1.058.887 | 0 | 1 | $-9.589 |
| Martin Wilson | — | 13 Ağustos 2026 S | 674.484 | 0 | 1 | $-11.806 |
| Christopher James Stevens | — | 11 Ağustos 2026 S | 505.784 | 0 | 1 | $-128.303 |
| Sarbani Chaudhuri | — | 11 Ağustos 2026 S | 262.809 | 0 | 1 | $-16.454 |
| David P Southwell | — | 03 Ağustos 2026 J | 204.522 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 2 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| RTW Investments, LP, Roderick Wong, M.D. ×4 başvurular | 16 Aralık 2024 | — | İlk başvuru | — | SEC |
| Care Capital III LLC, Care Capital Investments III LP, Care Capital Offshore Investments III LP, Care Capital II LLC, Care Capital Investments II LP, Care Capital Offshore Investments II LP | 10 Şubat 2017 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.